Annexon Inc

Research Annexon Inc (ANNX) on Bullrun: market cap USD 912.60M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANNX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 912.60M
• Financial periodFY2025
• Net income-USD 206.70M
• Free cash flow-USD 186.49M

Valuation Snapshot

latest market cap is USD 912.60M.

About Annexon Inc

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis.

Frequently asked questions

What is Annexon Inc's market cap?

Annexon Inc's market capitalization is USD 912.60M.

What does Annexon Inc do?

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.